We observed that GLP-1MK-801 and semaglutide elicited comparable glucose-lowering effects compared with vehicle and MK-801 monotherapy (Fig
Insurers are a major determinant of access, sometimes limiting use to specific diagnoses or patient populations
Individuals with uncontrolled hypertension, cardiovascular disease, or hyperthyroidism should avoid phentermine
In Feb26, Hernexeos (zongertinib) received FDA accelerated approval for advanced HER2-mutant NSCLC, based on a 76% objective response rate (N=72) in the Beamion LUNG-1 study, following Breakthrough Therapy Designation and prior approval in August 2025
Torres G, Morales PE, Garca-Miguel M, Norambuena-Soto I, Cartes-Saavedra B, Vidal-Pea G, Moncada-Ruff D, Sanhueza-Olivares F, San Martn A, Chiong M
Yet, I've had bouts of nausea with each of these medicines I tried